Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Medulloblastoma × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Polycystic Ovary Syndrome 8 Neoplasms 3 Endometrial Neoplasms 3 Prostatic Neoplasms 2 Obesity 2 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Diabetes Mellitus 2 Colorectal Neoplasms 2 Cognitive Dysfunction 2 Cardiotoxicity 2 Weight Gain 1 Vomiting 1 Venous Thromboembolism 1 Vascular Malformations 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1 Smoking 1 Skin Toxicity 1

Interventions

Cyclophosphamide 18 Temozolomide 15 Etoposide 15 Carboplatin 14 Filgrastim 13 Radiotherapy 10 Vincristine 9 Cisplatin 9 Thiotepa 8 Melphalan 8 Granulocyte Colony-Stimulating Factor 7 etoposide phosphate 6 Lomustine 6 Peripheral Blood Stem Cell Transplantation 5 Methotrexate 5 Magnetic Resonance Spectroscopy 5 Topotecan 4 Radiation 4 Busulfan 4 sargramostim 3 Thalidomide 3 Stem Cell Transplantation 3 Mesna 3 Irinotecan 3 Ifosfamide 3 Gemcitabine 3 Donepezil 3 Automobiles 3 sodium thiosulfate 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡